104 related articles for article (PubMed ID: 9817446)
1. Myasthenia gravis and tumor necrosis factor beta polymorphisms: linkage disequilibrium but no association beyond HLA-B8.
Manz MG; Melms A; Sommer N; Müller CA
J Neuroimmunol; 1998 Oct; 90(2):187-91. PubMed ID: 9817446
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor beta gene polymorphisms in myasthenia gravis.
Zelano G; Lino MM; Evoli A; Settesoldi D; Batocchi AP; Torrente I; Tonali PA
Eur J Immunogenet; 1998 Dec; 25(6):403-8. PubMed ID: 9949945
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
Huang DR; Pirskanen R; Matell G; Lefvert AK
J Neuroimmunol; 1999 Feb; 94(1-2):165-71. PubMed ID: 10376950
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis.
Fraile A; Nieto A; Beraún Y; Vinasco J; Matarán L; Martín J
Tissue Antigens; 1998 Apr; 51(4 Pt 1):386-90. PubMed ID: 9583811
[TBL] [Abstract][Full Text] [Related]
7. Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
Varade J; Wang N; Lim CK; Zhang T; Zhang Y; Liu X; Piehl F; Matell R; Cao H; Xu X; Hammarström L
J Autoimmun; 2018 Mar; 88():43-49. PubMed ID: 29037440
[TBL] [Abstract][Full Text] [Related]
8. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes.
Degli-Esposti MA; Andreas A; Christiansen FT; Schalke B; Albert E; Dawkins RL
Immunogenetics; 1992; 35(6):355-64. PubMed ID: 1349584
[TBL] [Abstract][Full Text] [Related]
9. TNFB gene polymorphism in insulin-dependent diabetes mellitus: association with HLA-DR alleles.
Newton DJ; Bowen-Jones D; Crosby I; Barnes RM; Flanagan BF
Eur J Immunogenet; 1998 Feb; 25(1):39-41. PubMed ID: 9587743
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes.
Selvaraj P; Sriram U; Mathan Kurian S; Reetha AM; Narayanan PR
Tuberculosis (Edinb); 2001; 81(5-6):335-41. PubMed ID: 11800584
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A
J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621
[TBL] [Abstract][Full Text] [Related]
12. A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.
Janer M; Cowland A; Picard J; Campbell D; Pontarotti P; Newsom-Davis J; Bunce M; Welsh K; Demaine A; Wilson AG; Willcox N
Hum Immunol; 1999 Sep; 60(9):909-17. PubMed ID: 10527401
[TBL] [Abstract][Full Text] [Related]
13. Association of four HLA class III region genomic markers with HLA haplotypes.
Pei J; Choo SY; Spies T; Strominger JL; Hansen JA
Tissue Antigens; 1991 May; 37(5):191-6. PubMed ID: 1685263
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in tumor necrosis factor genes associated with myasthenia gravis.
Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
J Neuroimmunol; 1998 Aug; 88(1-2):137-43. PubMed ID: 9688335
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
[No Abstract] [Full Text] [Related]
16. Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis.
Huang D; Pirskanen R; Hjelmström P; Lefvert AK
J Neuroimmunol; 1998 Jan; 81(1-2):76-81. PubMed ID: 9521608
[TBL] [Abstract][Full Text] [Related]
17. The impact of HLA on long-term outcome after thymectomy for myasthenia gravis.
Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
J Neuroimmunol; 1998 Aug; 88(1-2):177-81. PubMed ID: 9688339
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis and HLA antigens in American blacks and other races.
Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
[TBL] [Abstract][Full Text] [Related]
19. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
[TBL] [Abstract][Full Text] [Related]
20. TNFA and TNFB polymorphisms in myasthenia gravis.
Skeie GO; Pandey JP; Aarli JA; Gilhus NE
Arch Neurol; 1999 Apr; 56(4):457-61. PubMed ID: 10199335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
